Claim Missing Document
Check
Articles

Found 2 Documents
Search

Lactate Clearance sebagai Prediktor Mortalitas pada Pasien Sepsis Berat dan Syok Septik di Intesive Care Unit Rumah Sakit Dr. Hasan Sadikin Bandung Muhammad Budi Kurniawan; Erwin Pradian; Muthalib Nawawi
Jurnal Anestesi Perioperatif Vol 5, No 1 (2017)
Publisher : Faculty of Medicine, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (599.202 KB) | DOI: 10.15851/jap.v5n1.1003

Abstract

Tingkat mortalitas pasien sepsis berat di Intensive Care Unit (ICU) dihitung dengan menggunakan skor acute physiology and chronic health evaluation (APACHE II), namun memerlukan pemeriksaan yang banyak serta kompleks. Penurunan lactate clearance berhubungan dengan kondisi mikrosirkulasi yang buruk. Lactate clearance diharapkan memiliki kemampuan untuk menentukan tingkat mortalitas pasien sepsis berat dan syok septik. Penelitian ini bertujuan mengetahui kegunaan lactate clearance sebagai prediktor mortalitas pasien sepsis berat dan syok sepsis di ICU Rumah Sakit Dr. Hasan Sadikin (RSHS) Bandung yang lebih mudah dan efisien. Penelitian ini dilakukan secara prospektif observasional cohort terhadap 51 orang. Penelitian dilakukan di ICU RSHS Bandung dari bulan September–November 2015 dengan uji Mann Whitney pada data numerik dan Exact Fisher pada data kategorik. Setiap subjek penelitian diperiksa nilai laktat secara berkelanjutan pada jam pertama (H0) dan jam ke-24, kemudian dihitung nilai lactate clearance dengan rumus laktat awal-laktat serial/laktat awal x 100%. Subjek dibagi menjadi 2 kelompok berdasar atas nilai lactate clearance rendah (<40%) dan nilai lactate clearance tinggi (>40%). Hasil penelitian menunujukkan bahwa lactate clearance memiliki sensisitivitas 100%; spesifisitas 88,4%; nilai duga positif 89,2%; nilai duga negatif 100%; rasio kemungkinan positif 86,6%; rasio kemungkinan negatif 0 dan akurasi 94,11%. Simpulan penilitian adalah lactate clearance dapat digunakan sebagai prediktor mortalitas pada pasien sepsis berat dan syok septik di ICU RSHS Bandung.Kata kunci: Lactate clearance, mortalitas, sepsisLactate Clearance as Mortality Predictor in Severe Sepsis and Septic Shock Patient in Intensive Care Unit Dr. Hasan Sadikin General Hospital Bandung Mortality incidence predictor used for sepsis and shock septic in Intensive Care Unit (ICU) were measured using Acute Physiology and Chronic Health Evaluation (APACHE) II score, which needs many complex examinations. The purpose of this study was to examine lactate clearance as an alternative mortality predictor. Decreased percentage of lactate clearance is related to poor perfusion in microcirculation which leads to the possibility that lactate clearance can be used to predict mortality incidence in severe sepsis and shock septic patients in the ICU of Dr. Hasan Sadikin General Hospital Bandung. This was a prospective observational cohort study involving 51 patients who met sepsis and shock septic criteria during the period of September to November 2015. Lactate was examined continuously in all patients at first hour (H0) and H24 and then the lactate clearance value was measured using the following formula: lactate initial–lactate delayed/lactate initial x100%. Subjects were divided into two groups according to the low lactate clearance(<40%) and high lactate clearance (>40%). The Mann Whitney test was used for numeric data and exact Fisher test was used for categorical data. Results showed that the lactate clearance had a sensitivity of 100%, specificity of 88.4%, positive predictive value of 89.2%, negative predictive value of 100%, likelihood ratio positive of 86.6%, likelihood ratio negative of 0% and accuracy of 94.11%. Thus, lactate clearance can be used to predict mortality incidence in severe sepsis and shock septic patients.Key words: Lactate clearance, mortality, sepsis 
COMPARISON OF MYOCARDIAL PROTECTION EFFECTS BETWEEN SEVOFLURANE INHALATION ANESTHESIA AND PROPOFOL TOTAL INTRAVENOUS ANESTHESIA IN OFF-PUMP CORONARY ARTERY BYPASS SURGERY: A MULTICENTER STUDY Muhammad Fajar Sadli; Reza Widianto Sudjud; Muhammad Budi Kurniawan
Multidiciplinary Output Research For Actual and International Issue (MORFAI) Vol. 5 No. 3 (2025): Multidiciplinary Output Research For Actual and International Issue
Publisher : RADJA PUBLIKA

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54443/morfai.v5i3.3052

Abstract

Introduction: This study aimed to compare the myocardial protective effects of sevoflurane and propofol in patients undergoing Off-Pump Coronary Artery Bypass Grafting (OPCAB). Both anesthetic agents are commonly used in cardiac surgery; however, their relative efficacy in myocardial protection remains unclear. Methods: A total of 36 patients scheduled for elective OPCAB surgery were randomly assigned to two groups: 18 patients received sevoflurane, and 18 received propofol as anesthetic agents. Myocardial injury was assessed by measuring serum CK-MB levels at three time points: pre-induction (T0), 10 h post-surgery (T1), and 24 h post-surgery (T2). Left ventricular function was evaluated by measuring the ejection fraction (EF) preoperatively and postoperatively. Hemodynamic parameters (heart rate, mean arterial pressure, and central venous pressure) were monitored throughout the surgery. Postoperative recovery was assessed by measuring the duration of mechanical ventilation, ICU stay, and hospital stay. Statistical comparisons were made using appropriate tests (t-test, Mann-Whitney, and chi-square) with significance set at p < 0.05. Results: No significant differences were found in CK-MB levels between the sevoflurane and propofol groups at any of the three time points (T0, T1, and T2), indicating equivalent myocardial protection in both groups. The mean CK-MB values at T0, T1, and T2 were comparable between the sevoflurane (19.61 ± 88.081, 74.83 ± 70.503, 49.06 ± 44.421, respectively) and propofol groups (21.72 ± 10.532, 56.28 ± 32.807, 49.00 ± 29.019, respectively). Similarly, ejection fraction values were similar between the two groups preoperatively (sevoflurane: 50.01 ± 14.907%, propofol: 52.67 ± 13.676%) and postoperatively (sevoflurane: 50.72 ± 12.027%, propofol: 49.72 ± 12.136%). The hemodynamic parameters (heart rate, mean arterial pressure, and central venous pressure) were stable and comparable between the groups. Postoperative recovery outcomes, including mechanical ventilation duration, ICU stay, and hospital stay, were similar between the two groups. Conclusion: Sevoflurane and propofol provided equivalent myocardial protection during OPCAB surgery. These findings suggest that either anesthetic agent can be safely and effectively used for anesthesia management in OPCAB procedures without significant differences in myocardial injury or cardiac function.